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The national population-based breast screening program, BreastScreen Australia, was implemented in 1991 
with the objective of reducing breast 
cancer mortality through early detection 
of asymptomatic breast cancers using 
mammography. The target participation rate 
for biennial screening is 70% of all women 
aged 50–74 years, with the program having 
extended the upper target age range from 69 
to 74 years from 2013. However, this objective 
has not been met with rates remaining 
around 18% to 15% lower than the target 
since 1996 when uptake data began to be 
calculated.1-3 In addition, inequities between 
subgroups of women exist with Aboriginal 
and Torres Strait Islander women, referred 
to hereafter as Indigenous women, and 
women living remotely having the lowest 
rates of attendance at screening and relatively 
poorer breast cancer outcomes.4 The efficacy 
of breast screening in reducing mortality 
depends upon adequate population 
coverage,5 therefore improving participation 
across all groups of women is crucial to 
effective national cancer control.
The BreastScreen program was implemented 
in the Northern Territory (NT) in 1994. The 
NT has the smallest population in Australia 
dispersed across a geographical area that 
makes up 17.5% of the country’s total 
land mass.6 It has the lowest population 
density in Australia with the capital city, 
Darwin, classified as ‘outer regional’ based 
on the Australian Statistical Geographical 
Standards Remoteness Areas classification 
(ASGSRA).7 Furthermore, the NT has the 
highest proportion of Indigenous residents 
compared to other Australian states or 
territories, with up to 30% of the population 
identifying as Aboriginal and/or Torres Strait 
Islander. Regarding breast screening, the 
NT consistently has the lowest participation 
rates in the nation. NT Indigenous attendance 
is less than half of the national rate (24% 
vs. 55%, respectively) and the overall NT 
attendance (41%) is lower than all states 
and territories combined.2,8 Breast cancer is 
the most common non-melanoma cancer 
in Australian women and the number 
one cancer in NT women.8 Therefore, with 
evidence that screening prevents 43 deaths 
in 10,000 women screened,9 concerted efforts 
to improve screening attendance are needed.
A lower uptake of mammographic screening 
is not uncommon among Indigenous 
peoples around the world and the reasons 
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Abstract
Objective: To compare breast screening attendances of Indigenous and non-Indigenous 
women.
Methods: A total of 4,093 BreastScreen cases were used including 857 self-identified 
Indigenous women. Chi-squared analysis compared data between Indigenous and non-
Indigenous women. Logistic regression was used for groupings based on visits-to-screening 
frequency. Odds ratios and 95% confidence intervals were calculated for associations with low 
attendance.
Results: Indigenous women were younger and had fewer visits to screening compared with 
non-Indigenous women. Non-English speaking was mainly associated with fewer visits for 
Indigenous women only (OR 1.9, 95%CI 1.3-2.9). Living remotely was associated with fewer 
visits for non-Indigenous women only (OR 1.3, 95%CI 1.1-1.5). Shared predictors were younger 
age (OR 12.3, 95%CI 8.1-18.8; and OR 11.5, 95%CI 9.6-13.7, respectively) and having no family 
history of breast cancer (OR 2.1, 95%CI 1.3-3.3; and OR 1.8, 95%CI 1.5-2.1, respectively).
Conclusions: Factors associated with fewer visits to screening were similar for both groups 
of women, except for language which was significant only for Indigenous women, and 
remoteness which was significant only for non-Indigenous women. 
Implications for public health: Health communication in Indigenous languages may be key in 
encouraging participation and retaining Indigenous women in BreastScreen; improving access 
for remote-living non-Indigenous women should also be addressed.
Key words: breast cancer, screening, participation, Aboriginal and Torres Strait Islander
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for this are multifaceted. While some reasons 
for non-participation by Indigenous and 
non-Indigenous women may be similar, 
cultural beliefs around breast cancer and 
fatalistic views on health are reported as 
having significant influence on Indigenous 
screening behaviours.10 In addition, systematic 
barriers to screening are also evident for 
Indigenous Australians, including geographic 
isolation, lack of means of transportation to 
attend services, and a shortage of culturally 
competent facilitators to screening.11,12 
Evidence in the US, Canada, Alaska, Pacific 
Islands, and New Zealand show that 
Indigenous women are more likely to be 
underrepresented in breast screening13-15 
and have higher breast cancer mortality rates 
compared with non-Indigenous women.14-16 
A similar scenario is reported for Indigenous 
Australian women who, despite lower 
breast cancer incidence, have poorer health 
outcomes and higher rates of death from 
breast cancer when compared with other 
Australian women.17 Australian Indigenous 
women are also younger and more likely 
to have advanced tumours at the time of 
diagnosis compared with non-Indigenous 
women,18-20 making treatment options limited 
and the tumours potentially more aggressive. 
National and local strategies to improve 
accessibility have been implemented with 
some success, such as the mobile screening 
vans that travel to remote communities,21 the 
process of block bookings of appointments 
for Indigenous women,11 evidence-based and 
culturally sensitive materials developed by 
Indigenous health experts,22 and involvement 
of Indigenous health care workers.23 Despite 
these efforts, Indigenous Australians’ 
attendance at screening remains around 16% 
lower compared with non-Indigenous women 
(37% vs. 53%, respectively, in 2015) .
There is currently limited information on the 
screening characteristics of women in the NT 
as they relate to indigeneity and attendance. 
The aim of the current work is to investigate 
variables associated with attendance at 
BreastScreen for women in the NT. With 
significant differences shown previously 
between NT women in the screening 
population,24 a further aim is to measure the 
variations between Indigenous and non-
Indigenous women’s screening attendances. 
Methods
Data collection
Ethical approval was obtained from the 
Human Research Ethics Committee (HREC) 
of the NT Department of Health and Menzies 
School of Health Research (HREC 2016-2627). 
Written consent to use personal information 
for evaluation and research was collected 
from women prior to having a screening 
mammogram and only consenting women’s 
data was made available to researchers. 
This consent request is written in the client 
information form routinely collected by 
BreastScreen NT, a population screening 
program. 
The study was performed retrospectively 
using a client data sample retrieved from 
BreastScreen NT. The sample consisted 
of 4,093 women (857 self-identified as 
Indigenous and 3,236 reported being non-
Indigenous) aged between 40 and 85 years 
who were screened between 30 March and 
24 November 2015. BreastScreen NT sends 
postal invitations to women aged 50 to 74 
years old to attend screening every two years; 
however, screening is free for women from 40 
years of age. Mammograms were performed 
at permanent screening facilities in the NT 
in Darwin, Palmerston, and Alice Springs; 
women located in remote to very remote 
communities in the NT were screened via 
the BreastScreen NT mobile bus unit. Digital 
image files were sent electronically to Sydney 
Breast Clinic (SBC) in NSW for radiologist 
interpretation. 
Women’s radiologist-reported findings 
and self-reported personal details such as 
Indigenous status, date of birth, residential 
address, main language spoken, family 
history of breast cancer, previous breast 
cancer, current breast lump, and use of 
hormone replacement therapy (HRT) in 
the past six months were stored on the 
NT Department of Health computerised 
database. NT Department of Health personnel 
extracted the data and provided de-identified 
information to researchers. The number of 
screening rounds that a woman has attended 
was generated by the NT database system 
based on number of entries. Women’s 
residential postcodes were categorised 
by the researchers based on the ASGSRA 
classification. In the NT, only three categories 
are available: outer regional, remote and very 
remote. 
Data analysis
In the first stage of analysis, base-line 
differences between Indigenous and non-
Indigenous women’s characteristics and 
screening attendances were explored. Next, 
Receiver Operating Characteristics (ROC) 
curve analyses were employed for number of 
visits to screening and ages to determine cut-
off points for these variables for Indigenous 
and non-Indigenous women. Using these 
cut-off points, chi-squared tests were used to 
derive odds ratios (OR) and 95% confidence 
intervals (CI). A p-value <0.05 was considered 
significant. 
In the second stage of analysis, we 
investigated Indigenous and non-Indigenous 
women separately and focused on potential 
associations with numbers of visits to 
screening above and below the cut-off point. 
Categorical variables such as age group, 
previous breast cancer diagnosis, family 
history of breast cancer, main language, 
geographic remoteness, current breast lump, 
and case outcome were analysed using 
chi-squared tests. Logistic regression was 
used to derive odd ratios (OR) and 95% and 
confidence intervals (CI). Next, multivariate 
stepwise logistic regression was performed 
on variables with univariate significance to 
determine predictive factors for low screening 
attendance. Factors with p values <0.02 were 
retained in the model.
BM SPSS© version 24 statistical software was 
used for the analyses. 
Results
Women in this study had visited screening 
between one and 21 times in their lifetime. 
That is, for some women, this was their 
first time attending screening, for those on 
the highest end of the range it was their 
twenty-first visit, and other women ranged 
somewhere in between. Figure 1 displays 
the proportions of Indigenous and non-
Indigenous women according to the number 
of times they have attended screening. 
Table 1 shows that Indigenous women had 
fewer visits to screening compared with 
non-Indigenous women with medians of 
two visits (IQR 1-3) and three visits (IQR 
2-7), respectively. Indigenous women were 
younger than non-Indigenous women with 
median ages of 54 years (IQR 48-60 years) and 
57 years (IQR 52-63 years), respectively. 
There was a higher proportion of Indigenous 
women residing in remote areas (67.7%) 
compared with outer regional areas 
(13.3%), and 71.3% of Indigenous women 
mainly spoke another language at home. 
In contrast, non-Indigenous women had 
more than half of the population (56.9%) 
living in outer regional areas than in remote 
locations (36.2%), and 84.2% mainly spoke 
English at home. Both groups of women 
reported similar experiences with HRT use 
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and personal and family histories of breast 
cancer with greater proportions answering 
negatively. Further similarities were shown 
in that larger proportions of Indigenous and 
non-Indigenous women reported no breast 
lump at screening, and majorities in both 
groups had normal mammograms at this 
round of screening. 
ROC curve analyses determined that 55 years 
and 3 visits were the cut off-points for age 
and frequency of attendance at screening, 
respectively, as shown in Table 2. Indigenous 
women were 1.8 times as likely to be under 
55 years of age (OR 1.8, 95%CI 1.5–2.0; 
p<0.001) and more than 3 times as likely to 
have fewer than 3 visits to screening (OR 3.3, 
95%CI 2.8–3.9; p<0.001) than non-Indigenous 
women.
Table 3 shows the unadjusted results of the 
two-tailed tests based on screening visits 
above and below the cut-off point. The 
following describes the variables associated 
with low screening attendance (<3 visits). 
Women were likely to have attended 
screening less than 3 times if: they were 
younger than 55 years compared with 
older women (Indigenous: OR 10.8, 95%CI 
7.4–15.7; p<0.001; and non-Indigenous: OR 
10.7, 95%CI 9–12.6; p<0.001), had not had a 
previous breast cancer diagnosis compared 
with women who had a been diagnosed 
with breast cancer in the past (Indigenous: 
OR 7.5, 95%CI 2.0–28.0; p<0.001; and non-
Indigenous: OR 2.0, 95%CI 1.2–3.4; p<0.05); 
live in remote locations compared with 
non-remote women (Indigenous: OR 1.5, 
95%CI 1.1–2.4; p<0.05; and non-Indigenous: 
OR 1.5, 95%CI 1.3–1.7; p<0.001), and if they 
do not have a family history of breast cancer 
compared with women who do (Indigenous: 
OR 2.3, 95%CI 1.6–3.3; p<0.001; and non-
Indigenous: OR 1.3, 95%CI 1.1–1.5; p<0.001).
Speaking a main language other than English 
was associated with low attendance for 
Indigenous women (OR 2.3, 95%CI 1.7–3.2; 
p<0.001) but not for non-Indigenous women, 
while presenting with a current breast lump 
was significant for non-Indigenous women 
(OR 1.8, 95%CI 1.3–2.7; p<0.05) but not for 
Indigenous women.
Both Indigenous and non-Indigenous women 
whose cases were recalled to assessment at 
the time of data collection were likely to have 
had fewer visits to screening than cases that 
were reported as normal (Indigenous: OR 5.4, 
95%CI 2.1–13.6; p<0.001; non-Indigenous: OR 
1.9, 95%CI 1.4–2.6; p<0.001).
Multiple logistic regression analysis reported 
that significant predictors for low screening 
Figure 1 Distribution of Indigenous (n=857) and non-Indigenous women (n=3236) per 
number of visits to BreastScreen NT in 2015.
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Figu e 1: Distribution of Indigenous (n=857) and non-Indigenous women (n=3236) per number of visits to 
BreastScreen NT in 2015.
Table 1: Characteristics of Indigenous and non-Indigenous women screened in the NT in 2015.
Variables Indigenous  
N=857
Non-Indigenous  
N=3,236
Median age (y) at screening (Q1, Q3) 54 (48,60) 57 (52,63)
 min, max age (y) at screening 40,79 40,85
Median number of screening visits (Q1, Q3) 2 (1,3) 3 (2,7)
 min, max number of screening visits 1,19 1,21
Place of residencea (%)
 Outer regional 118 (13.3) 1,823 (56.9)
 Remote 579 (67.7) 1,172 (36.2)
 Very remote 159 (18.6) 209 (6.5)
Main languageb (%)
 English 245 (28.7) 2,721 (84.2)
 Other-language 610 (71.3) 511 (15.8)
HRT use within 6 monthsc (%)
 No 840 (98) 2,950 (91.4)
 Yes 17 (2) 278 (8.6)
Family history of breast cancerd (%)
 No 613 (80.7) 1,961 (66.1)
 Yes 147 (19.3) 1,007 (33.9)
Previous breast cancer (%)
 No 485 (98.6) 3,161 (97.7)
 Yes 12 (1.4) 75 (2.3)
Current breast lump (%)
 No 828 (96.6) 3,121 (96.4)
 Yes 29 (3.4) 115 (3.6)
Case decision (%)
 Normal 729 (92.4) 3,039 (93.9)
 Recalled 65 (7.6) 197 (6.1)
Notes: 
a: Visitors (n=33) were excluded 
b: Not known (n=6) was excluded 
c: Not known (n=1) was excluded 
d: Not known (n=365) were excluded
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Table 2: OR and 95% CI of Indigenous and non-Indigenous women’s cut-off ages and number of visits to screening.
Variables Indigenous 
N=857
non-Indigenous 
N=3,236
P value OR (95% CI)
<55 years 458 (53.4%) 1,269 (39.2%) < 0.0001 1.8 (1.5-2.0)
≥55 years 399 (46.6%) 1,967 (60.8%)
<3 visits 607 (70.8%) 1,360 (42%) < 0.0001 3.3 (2.8-3.9)
≥3 visits 250 (29.2%) 1,876 (58%)
Notes:
P values obtained from Chi-squared test
Table 3: Association of factors with screening attendance for Indigenous (n=857) and non-Indigenous (n=3,236) women in BreastScreen NT.
Variable Indigenous Non-Indigenous  
Less than 3 
visits N (%)
3 or more  
visits N (%)
P value OR (95% CI) 
reference is 1
Less than 3 
visits N (%)
3 or more 
visits N (%)
P value OR (95% CI)  
   reference is 1
Age
 <55 years 416 (90.8) 42 (9.2) < 0.001 10.8 (7.4-15.7) 942 (74.2) 327 (25.8) < 0.001 10.7 (9-12.6)
 ≥55 years 191 (47.9) 208 (52.1) 418 (21.3) 1,549 (78.7)
Previous breast cancer
 No 604 (71.5) 241 (28.5) < 0.001 7.5 (2.0-28.0) 1,340 (42.4) 1,821 (57.6) < 0.05 2.0 (1.2-3.4)
 Yes 3 (25) 9 (75) 20 (26.7) 55 (73.3)
Case decision
 Recalled 60 (92.3) 5 (7.7) < 0.001 5.4 (2.1-13.6) 113 (57.4) 84 (42.6) < 0.001 1.9 (1.4-2.6)
 Normal 547 (69.1) 245 (30.9) 1,247 (41) 1,792 (59)
Family history of breast cancer
 No 461 (75.2) 152 (24.8) < 0.001 2.3 (1.6-3.3) 856 (43.7) 1,105 (56.3) < 0.05 1.3 (1.1-1.5)
 Yes 84 (57.1) 63 (42.9) 374 (37.1) 633 (62.9)
Main language
 Other language 464 (76.1) 146 (23.9) < 0.001 2.3 (1.7-3.2) 199 (38.9) 312 (61.1) 0.129 0.8 (0.7-1.0)
 English 141 (57.6%) 104 (42.4) 1,158 (42.6) 1,563 (57.4)
Place of residence
 Remote 533 (72.2) 205 (27.8) < 0.05 1.5 (1.1-2.4) 647 (46.8) 735 (53.2) < 0.001 1.5 (1.3-1.7)
 Non-remote 74 (62.2) 45 (37.8) 694 (37.9) 1,139 (62.1)
Current breast lump
 Yes 22 (75.9) 7 (24.1) 0.544 1.3 (0.6-3.1) 65 (56.5) 50 (43.5) < 0.05 1.8 (1.3-2.7)
 No 585 (70.7) 243 (29.3) 1,295 (41.5) 1,826 (58.5)
HRT within 6 months  
 No 598 (71.2) 242 (28.8) 0.101 2.2 (0.8-5.8) 1,245 (42.1) 1,712 (57.9) 0.723 1.0 (0.8-1.3)
 Yes 9 (52.9) 8 (47.1) 114 (41.1) 164 (59)
Note:
P values derived from Chi-squared test
attendance for Indigenous women were 
younger age (OR 12.3, 95%CI 8.1–18.8; 
p<0.001), being recalled to assessment during 
this screening round (OR 5.4, 95%CI 1.8–13; 
p<0.001), no family history of breast cancer 
(OR 2.1, 95%CI 1.3–3.3; p<0.02), and mainly 
speaking a language other than English (OR 
1.9, 95%CI 1.3–2.9; p<0.02). Remoteness 
and having no past breast cancer diagnosis, 
which had univariate significance, were non-
significant and removed from the model. For 
non-Indigenous women, predictors for low 
screening attendance were younger age (OR 
11.5, 95%CI 9.6–13.7; p<0.001), being recalled 
to assessment during this screening round 
(OR 1.8, 95%CI 1.3–2.6), no family history 
of breast cancer (OR 1.8, 95%CI 1.5–2.1; 
p<0.001), and living remotely (OR 1.3, 95%CI 
1.1–1.5; p<0.02). Presenting with a current 
breast lump and no previous breast cancer 
diagnosis, which had univariate significance, 
were non-significant and removed from the 
model. These results are shown in Figure 2.
Discussion
It is widely reported that Indigenous 
Australian women have a lower survival rate 
and a younger age profile when diagnosed 
with breast cancer in comparison with their 
non-Indigenous counterparts.4 It is also well 
documented that Indigenous women have 
consistently lower attendance at screening 
for breast and cervical cancers than the rest 
of the population.1,17 However, in recent 
years, a 5% increase in national breast 
screening participation has been reported 
for Indigenous women aged 50–69 years, 
whereas the overall rate for the entire target 
population has remained steady.2 Also, more 
of the screening rounds for Indigenous 
women were initial screens than for other 
women,25 a report in line with the findings of 
this study. The increased national Indigenous 
participation rate, although still about 19% 
lower compared with the general population, 
is a positive step towards better Indigenous 
population coverage. The improvement 
may be attributed to the BreastScreen 
National Accreditation Standards (NAS) 
which recommend BreastScreen services 
to implement strategies that increase 
access and participation for underserved 
populations. Some of the ways in which 
BreastScreen is trying to reduce systematic 
barriers to screening are, improved record-
keeping of Indigenous data, targeted and 
culturally appropriate health promotion, 
growing the Indigenous health workforce, 
and more access points for consumers to 
screening sites.1,26,27 However, closing the 
gap on breast screening participation is 
a complex challenge that requires deep 
understanding of the logistical, cultural and 
health communication needs of Indigenous 
Australians.11
Tapia et al.
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Our results show that younger Indigenous 
women were more likely to have attended 
BreastScreen for the first and second time 
in 2015 than older Indigenous women and 
non-Indigenous women. This suggests 
that young Indigenous women, arguably a 
critical target group given the age profile of 
breast cancer in Indigenous Australians,4 are 
demonstrating initial engagement with the 
screening program. What our data do not 
show, however, is whether these Indigenous 
women are likely to have continuous and 
regular attendance at screening beyond their 
second visit. While limited with the absence 
of women’s data over time, our findings 
could imply that although young Indigenous 
women are engaging with initial screening, 
significant attrition may be occurring after 
the second visit. With BreastScreen Australia’s 
aim of reducing breast cancer mortality 
through early detection, women’s ongoing 
participation in the program is critical.
Association between low attendance 
and living remotely are shown for both 
Indigenous and non-Indigenous women; 
however, it only remains significant in the 
multivariate model for Indigenous women. 
Geographic remoteness is widely reported to 
present barriers to screening in Australia1,17 
and is of particular importance in the NT, 
with approximately two-thirds of the overall 
population living in remote to very remote 
locations.28 There have been national efforts 
to improve access to screening via the mobile 
screening van that travels to remote areas 
and indeed may account for the increase in 
participation of NT women in recent years.8 
However, overall participation rates are 
still lower compared with other states and 
territories of Australia, and evidence of poorer 
overall health continues to be reported with 
increasing geographic remoteness.29-32 
The characteristic that was significant for 
Indigenous women but not for others in our 
dataset was language, in that Indigenous 
women who mainly spoke a language other 
than English were likely to have fewer than 
three attendances compared with English-
speaking Indigenous women and compared 
with other women. This result, coupled 
with the earlier finding that Indigenous 
compared with non-Indigenous women 
were more likely to attend BreastScreen for 
the first and second time in 2015, suggests 
that Indigenous women are engaging with 
initial screening in the NT, where culturally 
and linguistically appropriate strategies have 
been implemented to meet the needs of 
Indigenous peoples.8 However, our results 
also imply that continued attendance 
beyond three visits may wane with those 
for whom English is not the main spoken 
language, a finding supported by other 
researchers who have shown that language 
can be a significant barrier to health for many 
Indigenous cultures around the world.10,13,33,34 
For example, it is reported that there is 
no word for cancer in many Indigenous 
languages, including Australian languages, 
which immediately presents difficulties 
when promoting screening.35 While it is well 
established that women of diverse cultural 
backgrounds have historically lower uptake 
to screening in Australia,1,27 tracking whether 
these women remain in the program beyond 
their initial attendance as a true measure of 
appropriate engagement in NT should be the 
focus of further work. 
Non-Indigenous women presenting with a 
current breast lump were associated with 
having fewer than three visits to screening in 
the unadjusted results. While BreastScreen 
Australia (BSA) targets asymptomatic women, 
there is a small group of women who present 
to screening with symptoms, particularly 
in the early screening rounds. The reported 
rate of symptomatic screening according 
to BreastScreen screening data from 1996 
to 2005 is slightly higher for Indigenous 
women than non-Indigenous women.25 Our 
study, however, found the opposite – that 
the association with a current breast lump 
only had univariate significance for non-
Indigenous women. A study in Finland which 
included self-reported or radiographer-
reported breast lumps in 1.3% of women 
screened in a population-based program 
found that the risk of breast cancer was 
sevenfold for women with lumps reported at 
screening compared to women with other 
symptoms (including nipple retractions 
and secretions).36 Given that the risk is high 
for women with breast lumps reported at 
screening, and with screening attendance 
for all women being lower than the national 
average in the NT, improving participation in 
BreastScreen NT is critically important.
A factor previously associated with low 
screening re-attendance in Australia and 
elsewhere is when a woman was previously 
recalled to assessment with a false-positive 
result.2,37,38 In the first round of screening, 
with high recall rates (up to 10.8% reported 
in 2012),29 and low positive predictive values 
(1.1% of women attending a first screen 
in 2015 had an invasive breast cancer or 
DCIS detected),2 low return attendance of 
recalled women in subsequent rounds is 
unsurprising. Maintaining high sensitivity 
and specificity in the BreastScreen program 
is one of the overarching goals of the NAS 
and therefore this must be evident, even 
with the first screening round.27 Our results 
show that women who had attended fewer 
screenings happened to have been recalled 
to assessment in this round; however, 
limitations in the data mean we can only 
estimate how a false positive would affect 
these women’s decisions about subsequent 
screening rounds. The current work reaffirms 
the importance of diagnostic efficacy to  
Figure 2. Factors associated with less than 3 screening visits for Indigenous (n=857) and 
non-Indigenous women (n=3236) in the NT. 
 
Figure 2: Factors associated with less than 3 screening visits for Indigenous (n=857) and non-Indigenous women 
(n=3,236) in the NT.
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long-term BreastScreen engagement and 
provides new evidence that this finding is not 
unique to any single grouping of women.
To improve access and program retention 
for diverse groups within the screening 
population, the NAS recommend Screening 
and Assessment Services (SAS) to provide 
equitable service to women who are 
culturally and linguistically diverse, are 
Indigenous, live in rural and remote areas and 
are from lower socioeconomic backgrounds.26 
Although an evaluation of the program in 
2014 found that BreastScreen Australia SAS 
uniformly performed well across the high-
priority standards and performance indicators 
(for benign biopsy rates, cancer detection 
rates and interval cancer rates), researchers 
reported that SAS with high numbers of 
diverse participants failed to meet the 
standard for time between screening 
and assessment.27 That is, attendance at 
assessment within the recommended 28 days 
after being recalled was lower for services 
with high cultural diversity. The reasons are 
unclear and warrant further investigation; 
however, the concern is that longer times to 
assessment may affect health outcomes for 
these women. While strategies have been 
implemented at state levels to try to increase 
screening participation, attendance at post-
screening assessment should be carefully 
considered at the SAS level, particularly for 
Indigenous women who are reportedly less 
likely to attend post-screening assessment 
within the recommended 28 days.25 
There were a few limitations in this study. 
Longitudinal data would have allowed us 
to provide a broader scope of women’s 
attendance at BreastScreen in the NT. As data 
were only collected from an eight-month 
period in a program of biennial screening, 
the information about women’s screening 
behaviours over time could not be surmised. 
A further limitation of this study is the lack 
of historical clinical information on women, 
such as the result of prior screening rounds, 
as a previous false positive finding is shown to 
affect future screening attendance. 
Conclusion
The current work corroborates previously 
reported variations between Indigenous 
and non-Indigenous women’s screening 
characteristics and provides evidence 
of factors strongly associated with low 
program attendance. Given the disparity 
in participation rates and known variations 
in breast cancer incidence, mortality and 
survival for Indigenous and non-Indigenous 
women, strategies to optimise engagement 
with the screening program should be 
targeted to meet the logistical, cultural and 
health communication needs of Australian 
women.
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